SG97890G - Antiparasitic non-aqeous formulation containing an avermectin or milbemycin - Google Patents

Antiparasitic non-aqeous formulation containing an avermectin or milbemycin

Info

Publication number
SG97890G
SG97890G SG978/90A SG97890A SG97890G SG 97890 G SG97890 G SG 97890G SG 978/90 A SG978/90 A SG 978/90A SG 97890 A SG97890 A SG 97890A SG 97890 G SG97890 G SG 97890G
Authority
SG
Singapore
Prior art keywords
avermectin
milbemycin
antiparasitic
aqeous
formulation containing
Prior art date
Application number
SG978/90A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SG97890G publication Critical patent/SG97890G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG978/90A 1983-12-22 1990-12-10 Antiparasitic non-aqeous formulation containing an avermectin or milbemycin SG97890G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56414083A 1983-12-22 1983-12-22

Publications (1)

Publication Number Publication Date
SG97890G true SG97890G (en) 1991-02-14

Family

ID=24253315

Family Applications (1)

Application Number Title Priority Date Filing Date
SG978/90A SG97890G (en) 1983-12-22 1990-12-10 Antiparasitic non-aqeous formulation containing an avermectin or milbemycin

Country Status (17)

Country Link
EP (1) EP0146414B1 (fr)
JP (1) JPH0623100B2 (fr)
KR (1) KR880002366B1 (fr)
AT (1) ATE47522T1 (fr)
AU (1) AU560864B2 (fr)
CA (1) CA1267844A (fr)
DE (1) DE3480263D1 (fr)
DK (1) DK164772C (fr)
ES (1) ES8608888A1 (fr)
GR (1) GR81244B (fr)
HK (1) HK5091A (fr)
IE (1) IE57681B1 (fr)
IL (1) IL73800A (fr)
NZ (1) NZ210505A (fr)
PT (1) PT79656B (fr)
SG (1) SG97890G (fr)
ZA (1) ZA849841B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284176B1 (fr) * 1987-01-23 1993-08-25 Pfizer Inc. Procédé pour la production d'avermectines et les cultures utilisées
US5075307A (en) * 1987-07-28 1991-12-24 Merck & Co., Inc. Paraherquamide and dihydroparaherquamide as antihelminthic agents
GB8803836D0 (en) * 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
US6001822A (en) * 1989-04-11 1999-12-14 Pfizer Inc. Antiparasitic formulations
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
GB2275193A (en) * 1993-02-17 1994-08-24 Merck & Co Inc Formulations for the topical delivery of avermectins
PL174488B1 (pl) * 1993-05-10 1998-08-31 Merck & Co Inc Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt
DE69432982T2 (de) * 1993-05-10 2004-04-15 Merck & Co., Inc. Pour-on formulierung enthaltend polymerische material, glykole und glyzeriden
US5602107A (en) * 1993-05-10 1997-02-11 Merck & Co., Inc. Pour-on formulations consisting of gylcols, glycerides and avermectin compounds
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US6054140A (en) * 1997-03-21 2000-04-25 Biogenesis S.A. Long acting injectable parasiticidal composition and the process for its preparation
AR013202A1 (es) * 1997-07-10 2000-12-13 Biotech Australia Pty Ltd Vacunas no acuosas
GB9816132D0 (en) * 1998-07-24 1998-09-23 Norbrook Lab Ltd Non-aqueous anthelmintic composition
AU733095B3 (en) * 1999-09-22 2001-05-03 Ashmont Holdings Limited Sheep pour on
JP2001253824A (ja) * 2000-03-14 2001-09-18 Mitsukazu Matsumoto 局所注射用処方剤
GR1003969B (el) * 2001-02-05 2002-08-14 U��-Pharma ����� ������ ������������ ���������� ���� Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.
US6627613B2 (en) 2001-07-23 2003-09-30 Michael A. Strobel Application of water and organic solvent soluble ivermectin for topical and oral use
US20050009762A1 (en) 2003-06-06 2005-01-13 Strobel Michael Albert Application of water and organic solvent soluble ivermectin for topical and oral use
GB2386066A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
UY27412A1 (es) * 2002-08-12 2003-06-30 Carlson Internat Inc Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn.
GB0316377D0 (en) 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
JP4886214B2 (ja) * 2005-05-24 2012-02-29 日本パワーファスニング株式会社 石膏ボード締結用の2条式木ねじ
RU2493825C2 (ru) 2008-10-08 2013-09-27 ВАЙЕТ ЭлЭлСи Бензимидазольные антигельминтные композиции
JP5607114B2 (ja) 2012-06-26 2014-10-15 株式会社トープラ タッピンねじ
JP2024516912A (ja) 2021-05-14 2024-04-17 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト 昆虫、ダニ目及び線虫有害生物の防除
WO2022268815A1 (fr) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Lutte contre les insectes, les acariens et les nématodes nuisibles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4130651A (en) * 1978-03-31 1978-12-19 American Cyanamid Company Butamisole injectable formulations having improved margin of safety in dogs
NZ197796A (en) * 1980-08-04 1984-11-09 Merck & Co Inc Stabilised aqueous formulations containing ivermectin
US4430329A (en) * 1982-05-17 1984-02-07 Merck & Co., Inc. Synergistic treatment of adult canine heartworm with thiacetarsamide and ivermectin

Also Published As

Publication number Publication date
EP0146414B1 (fr) 1989-10-25
AU3702484A (en) 1985-07-04
ES538750A0 (es) 1986-07-16
EP0146414A3 (en) 1986-12-10
ES8608888A1 (es) 1986-07-16
PT79656B (en) 1987-01-16
ZA849841B (en) 1986-07-30
IL73800A (en) 1987-11-30
IE843221L (en) 1985-06-22
GR81244B (en) 1985-04-16
JPS60169415A (ja) 1985-09-02
DK164772B (da) 1992-08-17
DE3480263D1 (en) 1989-11-30
KR850004391A (ko) 1985-07-15
NZ210505A (en) 1988-06-30
DK619784A (da) 1985-06-23
KR880002366B1 (ko) 1988-11-03
DK164772C (da) 1993-01-04
ATE47522T1 (de) 1989-11-15
HK5091A (en) 1991-01-18
JPH0623100B2 (ja) 1994-03-30
CA1267844A (fr) 1990-04-17
IE57681B1 (en) 1993-02-24
AU560864B2 (en) 1987-04-16
DK619784D0 (da) 1984-12-21
PT79656A (en) 1985-01-01
EP0146414A2 (fr) 1985-06-26
IL73800A0 (en) 1985-03-31

Similar Documents

Publication Publication Date Title
AU560864B2 (en) Pharmaceutical parenteral compositions of an avermectin and propylene glycol
ES8607721A1 (es) Un procedimiento para la solubilizacion y estabilizacion de un agente antiparasitario.
EP0928136A4 (fr) Compositions injectables
ES8608875A1 (es) Un metodo para preparar una composicion farmaceutica para aplicacion topica que contiene 1-dodecilazacicloheptan-2-ona.
CA2004598A1 (fr) Aerosols medicinaux
EP0222614A3 (fr) Formulations pharmaceutiques à libération prolongée administrables par voie orale
IE873125L (en) Benzimidazole derivatives
IT8323956A0 (it) Antibiotici macrolidi e preparazione orale stabile di procedimento di stabilizzazione.
ATE223221T1 (de) Lösliche arzneizusammensetzungen enthaltend 2- chloro-2'-deoxyadenosine
IT8622347A0 (it) Procedimento per la preparazione di polieteri alogenati.
NO168648C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive nitrogenholdige derivater av epipodofyllotoksin-glukosidderivater.
IE810891L (en) Topical formulation
ES284914Y (es) Dispositivo para la administracion percutanea de un principio activo.
IL104886A0 (en) Adenine derivatives and pharmaceutical compositions containing the same
ES2040774T3 (es) Procedimiento para la preparacion de una formulacion medicamentosa.
EP0093497A3 (fr) Traitement anthelminthique
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
NO160142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (1,2,4)triazolo(4,3-a)kinoksalin-4-amin-derivater.
ES2007040A6 (es) Un forma de dosificacion para descargar un agente benificioso a un entorno fluido de uso
NO166366C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cycloalkan (1,2-c:4,3-c')dipyrazoler.
GB8620361D0 (en) Pharmaceutical compositions
TH22662A (th) สารสูตรผสมของ 2-คลอโร-2'-ดีออกซิแอดีโนซินชนิดละลาย?ได้
IT1255696B (it) Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
DK69287A (da) Temazepamkomposition og fremgangsmaade til fremstilling af samme
IT7922269A0 (it) Preparati di corticosteroidi per somministrazione orale.